Similar articles

• Discontinuation of statins in routine care settings.

  Zhang H, Plutzky J, Turchin A. Zhang H, et al. Ann Intern Med. 2013 Jul 2;159(1):75-6. doi: 10.7326/0003-4819-159-1-201307020-00022. Ann Intern Med. 2013. PMID: 23817716 No abstract available.
• Discontinuation of statins in routine care settings.

  de Groen PC. de Groen PC. Ann Intern Med. 2013 Jul 2;159(1):74. doi: 10.7326/0003-4819-159-1-201307020-00020. Ann Intern Med. 2013. PMID: 23817714 No abstract available.
• Discontinuation of statins in routine care settings.

  LeBlanc TW, Kutner JS, Ritchie CS, Abernethy AP. LeBlanc TW, et al. Ann Intern Med. 2013 Jul 2;159(1):74-5. doi: 10.7326/0003-4819-159-1-201307020-00021. Ann Intern Med. 2013. PMID: 23817715 No abstract available.
• Treatment of childhood hypercholesterolemia with HMG-CoA reductase inhibitors.

  Duplaga BA. Duplaga BA. Ann Pharmacother. 1999 Nov;33(11):1224-7. doi: 10.1345/aph.19078. Ann Pharmacother. 1999. PMID: 10573325 Review.
• [ANMCO Position paper: Diagnostic and therapeutic pathways in patients with hypercholesterolemia and statin intolerance].

  Gulizia MM, Colivicchi F, Arca M, Abrignani MG, Perna GP, Mureddu GF, Nardi F, Riccio C; ANMCO. Gulizia MM, et al. G Ital Cardiol (Rome). 2016 Jun;17(6):447-55. doi: 10.1714/2262.24348. G Ital Cardiol (Rome). 2016. PMID: 27311087 Italian.